The Complex Link and Disease Between the Gut Microbiome and the Immune System in Infants DOI Creative Commons
Huan Zhang, Zhilin Zhang, Yiqun Liao

et al.

Frontiers in Cellular and Infection Microbiology, Journal Year: 2022, Volume and Issue: 12

Published: June 15, 2022

The human gut microbiome is important for health. development of stable microbial communities in the gastrointestinal tract closely related to early growth and host immunity. After birth a baby, immune cells mature parallel adapt complex environment. linked system influences each other. This interaction associated with various diseases infants young children, such as asthma, food allergies, necrotizing colitis, obesity, inflammatory bowel disease. Thus, composition infant can predict risk disease progression. At same time, be regulated many ways used prevent treat by modulating microbiome. most impacts on microbiota are maternal, including delivery feeding. differences reflect maternal microbiota, which turn reflects given population, clinically significant.

Language: Английский

Functional effects of human milk oligosaccharides (HMOs) DOI Creative Commons
Meltem Dinleyici,

Jana Barbieur,

Ener Çağrı Dinleyici

et al.

Gut Microbes, Journal Year: 2023, Volume and Issue: 15(1)

Published: March 17, 2023

Human milk oligosaccharides (HMOs) are the third most important solid component in human and act tandem with other bioactive components. Individual HMO levels distribution vary greatly between mothers by multiple variables, such as secretor status, race, geographic region, environmental conditions, season, maternal diet, weight, gestational age mode of delivery. HMOs improve gastrointestinal barrier also promote a bifidobacterium-rich gut microbiome, which protects against infection, strengthens epithelial barrier, creates immunomodulatory metabolites. fulfil variety physiologic functions including potential support to immune system, brain development, cognitive function. Supplementing infant formula is safe promotes healthy development revealing benefits for microbiota composition infection prevention. Because limited data comparing effect non-human HMOs, it not known if offer an additional clinical benefit over oligosaccharides. Better knowledge factors influencing their will help understand short- long-term benefits.

Language: Английский

Citations

94

The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome DOI Open Access

Giulia Catassi,

Marina Aloi, Valentina Giorgio

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(3), P. 400 - 400

Published: Jan. 30, 2024

The infant gut microbiome plays a key role in the healthy development of human organism and appears to be influenced by dietary practices through multiple pathways. First, maternal diet during pregnancy nutrition significantly influence microbiota. Moreover, breastfeeding fosters proliferation beneficial bacteria, while formula feeding increases microbial diversity. timing introducing solid foods also influences microbiota composition. In preterm infants is factors, including time since birth intake breast milk, interventions such as probiotics prebiotics supplementation show promising results reducing morbidity mortality this population. These findings underscore need for future research understand long-term health impacts these further strategies enrich formula-fed infants.

Language: Английский

Citations

25

Interactions of human milk oligosaccharides with the immune system DOI Creative Commons

A. Slater,

Rita M. Hickey, Gavin P. Davey

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 15

Published: Jan. 14, 2025

Human milk oligosaccharides (HMOs) are abundant, diverse and complex sugars present in human breast milk. HMOs well-characterized barriers to microbial infection by modulating the microbiome they also thought be nutritionally beneficial infant. The structural variety of over 200 HMOs, including neutral, fucosylated sialylated forms, allows them interact with immune system various ways. Clinically, impact allergic diseases, reducing autoimmune inflammatory responses, offer support preterm infant health. This review examines HMO composition associated immunomodulatory effects, interactions cell receptors gut-associated responses. These properties highlight potential for use early stage development as novel immunotherapeutics. research is rapidly evolving promises innovative treatments immune-related conditions improved health outcomes.

Language: Английский

Citations

2

Structure and function of non-digestible carbohydrates in the gut microbiome DOI Open Access
Robert A. Rastall, Marina Díez‐Municio, Sofia D. Forssten

et al.

Beneficial Microbes, Journal Year: 2022, Volume and Issue: 13(2), P. 95 - 168

Published: June 18, 2022

Together with proteins and fats, carbohydrates are one of the macronutrients in human diet. Digestible carbohydrates, such as starch, starch-based products, sucrose, lactose, glucose some sugar alcohols unusual (and fairly rare) α-linked glucans, directly provide us energy while other including high molecular weight polysaccharides, mainly from plant cell walls, dietary fibre. Carbohydrates which efficiently digested small intestine not available appreciable quantities to act substrates for gut bacteria. Some oligo- many also fibres, resistant digestion intestines enter colon where they complex bacterial ecosystem that resides there. This review will focus on these non-digestible (NDC) examine their impact microbiota physiological impact. Of particular be potential prebiotics, but evaluate direct effects NDC cells systems.

Language: Английский

Citations

63

Intestinal ‘Infant-Type’ Bifidobacteria Mediate Immune System Development in the First 1000 Days of Life DOI Open Access
Chunxiu Lin, Yugui Lin, Heng Zhang

et al.

Nutrients, Journal Year: 2022, Volume and Issue: 14(7), P. 1498 - 1498

Published: April 2, 2022

Immune system maturation begins early in life, but few studies have examined how early-life gut microbiota colonization educates the neonatal immune system. Bifidobacteria predominate intestines of breastfed infants and metabolize human milk oligosaccharides. This glycolytic activity alters intestinal microenvironment consequently stimulates at stage. However, provided mechanistic insights into contribution ‘infant-type’ Bifidobacterium species, especially via metabolites such as short-chain fatty acids. In this review, we highlight first 1000 days which provide a window opportunity for infant-type bifidobacteria to educate Furthermore, discuss instrumental role education by inducing tolerance suppressing inflammation, potential underlying mechanism effect life. We also summarize recent research that suggests administration helps modify microecology prevent progress immune-mediated disorders.

Language: Английский

Citations

56

Molecular strategies for the utilisation of human milk oligosaccharides by infant gut-associated bacteria DOI Creative Commons
L.J. Kiely,

Kizkitza Busca,

Jonathan A. Lane

et al.

FEMS Microbiology Reviews, Journal Year: 2023, Volume and Issue: 47(6)

Published: Oct. 4, 2023

Abstract A number of bacterial species are found in high abundance the faeces healthy breast-fed infants, an occurrence that is understood to be, at least part, due ability these bacteria metabolize human milk oligosaccharides (HMOs). HMOs third most abundant component after lactose and lipids, represent complex sugars which possess unique structural diversity resistant infant gastrointestinal digestion. Thus, reach distal intestine intact, thereby serving as a fermentable substrate for specific intestinal microbes, including Firmicutes, Proteobacteria, especially infant-associated Bifidobacterium spp. help shape gut microbiome. Bacteria utilising equipped with genes associated their degradation carbohydrate-active enzymes known glycoside hydrolase have been identified gut, supports this hypothesis. The resulting degraded can also be used growth substrates other present microbe-microbe interaction ‘cross-feeding’. This review describes current knowledge on HMO metabolism by particular gut-associated bacteria, many currently commercial probiotics, distinct strategies employed individual utilisation.

Language: Английский

Citations

26

Milk Bioactive Compounds and Gut Microbiota Modulation: The Role of Whey Proteins and Milk Oligosaccharides DOI Creative Commons
Valentina Gallo, Alyexandra Arienzo,

Federica Tomassetti

et al.

Foods, Journal Year: 2024, Volume and Issue: 13(6), P. 907 - 907

Published: March 16, 2024

A strong correlation between the occurrence of various pathological conditions and intestinal dysbiosis is supported by a range evidence. Vice versa, many pathologies have been shown, in turn, to be responsible for alterations gut microbiota, condition that can worsen illness outcomes response therapies. For these reasons, great efforts made, studies are still ongoing, elucidate mechanisms underlying microbiota search pharmacologic or other strategies effectively restore microbiota. In this narrative review, we examined most significant literature on role some milk bioactive compounds, such as oligosaccharides whey proteins, modulating composition action, with aim investigating impact changes mediated molecules human health, their potential use therapeutics treat adjuvate treatment associated pathologies.

Language: Английский

Citations

15

Preparation and synbiotic interaction mechanism of microcapsules of Bifidobacterium animalis F1–7 and human milk oligosaccharides (HMO) DOI
X. Y. Huang, Rui Liu, Jing Wang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 259, P. 129152 - 129152

Published: Jan. 2, 2024

Language: Английский

Citations

13

Enzymatic modular synthesis of asymmetrically branched human milk oligosaccharides DOI

Yinshuang Li,

Yi Li, Yuxi Guo

et al.

Carbohydrate Polymers, Journal Year: 2024, Volume and Issue: 333, P. 121908 - 121908

Published: Feb. 9, 2024

Language: Английский

Citations

10

Enzymatic and chemoenzymatic synthesis of human milk oligosaccharides and derivatives DOI
Jie Zheng, Xu Han, Junqiang Fang

et al.

Carbohydrate Polymers, Journal Year: 2022, Volume and Issue: 291, P. 119564 - 119564

Published: May 4, 2022

Language: Английский

Citations

38